medigraphic.com
ISSN 1810-2352 (Print)

2020, Number 2

<< Back

Rev Cub Med Int Emerg 2020; 19 (2)

Protocol for the treatment of COVID-19 disease (SARS-CoV-2) in obstetric patients admitted in intensive care

Pérez AA, Rivero MHB, Pereda GR, Breto GA, Piloto PM, Oviedo RR

Language: Spanish
References: 27
Page: 1-29
PDF size: 324.91 Kb.


ABSTRACT

Scope: This protocol will be applied to obstetric patients (pregnant and postpartum) admitted in an intensive care unit with confirmed diagnosis of COVID-19. Personnel to whom it is addressed: Intensive Medicine and Emergencies, Obstetrics and Gynecology specialist doctors and residents, and other specialists and professionals who provide medical care to obstetric patients admitted in an intensive care unit. General target: To establish the processes and procedures required for the treatment of the coronavirus 2 COVID-19 (SARS-CoV-2) disease in obstetric patients (pregnant and postpartum) who require intensive care admission. Validity: Until the next update. This protocol will be greatly improved when discussed among intensivists, obstetricians and specialists dedicated to the care of these patients. The experiences of other countries, regarding the evolution of the disease, the recommendations of international institutions and publications that are systematically reviewed on the subject, will serve to improve it. Hence, the successive versions will carry, in addition to the date of issue, the version in question. For this reason, this is the first version. Limitations: No actions are contemplated in primary care or in those patients with a less serious condition without a criteria for admission in intensive care. On the other hand, this protocol is supported by international guides and publications, since there are not obstetric patients diagnosed with this condition in Cuba.


REFERENCES

  1. - Caballero A, Caballero AD. Síndrome de distrés respiratorio agudo. En: Caballero A, Domínguez M, Pardo A, Abdo A, editores. Terapia Intensiva. 4aed. La Habana: ECIMED; 2019: vol. 3 p. 132-81.

  2. - World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected - Interim Guidance. 28 January 2020 [citado: 13/03/2020]. Disponible en: https://apps.who.int/iris/handle/10665/330893

  3. - Deng SQ, Peng HJ. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J Clin Med. 2020;9(2):E575. Doi: 10.3390/jcm9020575

  4. - Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. Doi: 10.1016/S0140-6736 (20) 30183-5

  5. - Wax AS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth. 2020 Feb 12. Doi: 10.1007/s12630-020-01591-x

  6. - Villegas-Chiroque M. Pandemia de COVID-19: pelea o huye. Rev Ev Exp Med. 2020;6(1):3-4.

  7. - Ríos-González CM. Implicancias del COVID-19, una nueva enfermedad producida por coronavirus. Medicina Clínica y Social. 2019;3(31):71-2.

  8. - Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases. J Clin Med. 2020;9(2). Doi: 10.3390/jcm9020523

  9. - Rajan R, Jarallah MAI, Dashti R. Cardiovascular complications of novel Wuhan Coronavirus (COVID-19) – A 2020 update. J Cardiol Curr Res. 2020;13(1). Doi: 10.15406/jccr.2020.13.00468

  10. - Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, et al. Acute Respiratory Distress Syndrome. Nat Rev Dis Primers;5(1):18. Doi: 10.1038/s41572-019-0069-0.

  11. - Hess DR, Kacmarek RM. Acute Respiratory Distress Syndrome. In: Hess DR, Kacmarek RM, editors. Essentials of Mechanical Ventilation. 3ered. New York: McGraw-Hill Education; 2014 p. 177-88.

  12. - España. Ministerio de Sanidad. Manejo clínico de pacientes con enfermedad por el nuevo coronavirus (COVID-19). 03 marzo 2020 [citado: 18/03/2020]. Disponible en: https://www.fundación.com/wp-content/uploads/2020/03/Protocolo_manejo_clinico_ tto_COVID-19-1.pdf

  13. - Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020 Feb 12. Doi: 10.1016/S0140-6736(20)30360-3

  14. - Ralph R, Lew J, Zeng T, Francis M, Xue B, Roux M, et al. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries. 2020;14(1):3-17. Doi:10.3855/jidc.12425

  15. - Ramos C. Covid-19: la nueva enfermedad causada por un coronavirus. Salud Pública de México. 2020;62(2):225-7. Doi: 10.21149/11276

  16. - Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. Doi: 10.1016/S0140-6736(20)30183-5

  17. - Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. Doi: 10.1056/NEJMoa2001017

  18. - Organización Mundial de la Salud. Situation report-41. Coronavirus disease 2019. 01 March 2020. Ginebra: OMS; 2020. [citado: 18/03/2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf?sfvrsn=6768306d_2

  19. - Xiao-Wei Xu, Xiao-Xin Wu, Xian-Gao Jiang, Kai-Jin Xu, Ling-Jun Ying, Chun-Lian Ma, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. Doi: 10.1136/bmj.m606

  20. - Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar 16;14(1):69-71. Doi: 10.5582/bst.2020.01020

  21. - Zuo M, Huang Y, Ma W, Xue Z, Zhang J, Gong Y, et al. Expert Recommendations for Tracheal Intubation in Critically ill. Chin Med Sci J. 2020 Feb 27. Doi: 10.24920/003724

  22. - Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle. J Med Virol. 2020;92(4):401-2. Doi: 10.1002/jmv.25678

  23. - Salem AH, Jones AK, Santini-Oliveira M, Taylor GP, Patterson KB, Nilius AM, et al. No need for lopinavir dose adjustment during pregnancy: a population pharmacokinetic and exposure-response analysis in pregnant and nonpregnant HIV-Infected subjects. Antimicrob Agents Chemother. 2015;60(1):400-8. Doi: 10.1128/AAC.01197-15

  24. - Schmid MB, Fontijin J, Ochsenbein-Kölble N, Berger C, Bassler D. COVID-19 in pregnant women. Lancet Infect Dis. 2020 Mar 17. Doi: 10.1016/S1473-3099(20)30175-4

  25. - Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis. 2020 Mar 3. Doi: 10.1016/S1473-3099(20)30157-2

  26. - Favre G, Pomar L, Musso D, Baud D. 2019-nCoV epidemic: what about pregnancies? The Lancet. 2020 Mar 03. Doi: 10.1016/S1473-3099(20)30157-2

  27. - Liang T. Handbook of COVID-19 prevention and treatment. Zhejiang: Zhejiang University School of Medicine; 2020.




2020     |     www.medigraphic.com